Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-08-045489
Filing Date
2008-07-14
Accepted
2008-07-14 17:04:47
Documents
5
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS LLCWARBURG PINCUS X LLCWARBURG PINCUS X PARTNERS, L.P.WARBURG PINCUS X, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D a08-18320_1sc13d.htm SC 13D 246463
2 EX-1 a08-18320_1ex1.htm EX-1 127888
3 EX-2 a08-18320_1ex2.htm EX-2 312616
4 EX-3 a08-18320_1ex3.htm EX-3 45462
6 GRAPHIC g183201ba01i001.gif GRAPHIC 73
  Complete submission text file 0001104659-08-045489.txt   734942
Mailing Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131
Business Address 288 FUTE ZHONG ROAD WAIGAOQIAO FREE TRADE ZONE SHANGHAI F4 200131 86-21-5046-1111
WuXi PharmaTech (Cayman) Inc. (Subject) CIK: 0001403132 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83350 | Film No.: 08951220
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017
Business Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017 212-878-0600
Warburg Pincus Private Equity X, L.P. (Filed by) CIK: 0001414565 (see all company filings)

EIN.: 200849130
Type: SC 13D